The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 33, Issue 6, 2004, Pages 327-334

  Liu, Chung Ji ^a,b   Chang, Kuo Wei ^b   Chao, Shou Yee ^b,c   Kwan, Po Cheung ^c   Chang, Shun Min ^b   Yen, Rui Yin ^b   Wang, Chun Yu ^b   Wong, Yong Kie ^b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Areca; Buccal mucosa; Catenin; Cyclin D1; MDM2, mouth neoplasm; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; MOLECULAR MARKER; PLAKOGLOBIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BETEL NUT; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TISSUE SECTION;

EID: 3142688942     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00092.x     Document Type: Article

References (39)

1. Chang KW, Chang CS, Lai KS, Chou MJ, Choo KB. High prevalence of human papillomavirus infection and possible association with areca quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989; 28: 57-61.
2. Yan JJ, Tzeng CC, Jin YT. Overexpression of p53 protein in squamous cell carcinomas of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study. J Oral Pathol Med 1996; 25: 55-9.
3. Wong YK, Liu TY, Chang KW, et al. p53 alterations in areca-quid and tobacco associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1998; 27: 243-8.
4. Chen YK, Huang HC, Liu CM, Lin CC. Primary oral squamous cell carcinoma, an analysis of 703 cases in Southern Taiwan. Oral Oncol 1999; 35: 173-9.
5. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN) 1: carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256-63.
6. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000; 36: 311-27.
7. Bishop M. Molecular themes in oncogenesis. Cell 1991; 64: 235-48.
8. Caamano J, Zhang SY, Rosvold EA, Bauer B, Klein-Szanto AJP. p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am J Pathol 1993; 142: 1131-9.
9. De Araujo VC, Loyola AM, Santos DD, Borra RC, De Araujo NS. p53 in biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system. Oral Oncol 1997; 33: 5-9.
10. Mineta H, Borg A, Dictor M, Wahlberg P, Wennerberg J. Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Oral Oncol 1997; 33: 42-6.
11. Agarwal S, Mathur M, Shukla NK, Ralhan R. Expression of cyclin dependent kinase inhibitor p21 in premalignant and malignant oral lesions: relationship with p53 status. Oral Oncol 1998; 34: 353-60.
12. van Oijen MGCT, Tilanus MGJ, Medema RH, Slootweg PJ. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 1998; 27: 367-75.
13. Chang KW, Lin SC, Kwan PC, Wong YK. Association of aberrant p53 and p21 (WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med 2000; 29: 56-62.
14. Ralhan R, Sandhya A, Meera M, Bohdan W, Nootan SK. Induction of MDM-P2 transcripts correlates with stabilized wild-type p53 in areca- and tobacco-related human oral cancer. Am J Pathol 2000; 157: 587-96.
15. Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y, Matsumura T. Alterations of Rb, p16 (INK 4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett 2000; 160: 3-8.
16. Huang JS, Ho TJ, Chiang JP, Kok SH, Kuo YS, Kuo MY. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 2001; 30: 53-8.
17. Millon R, Muller D, Schultz I, et al. Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance. Oral Oncol 2001; 37: 620-31.
18. Sherr CJ, Mammalian G1 cyclins. Cell 1993; 73: 1059-65.
19. Jiang W, Kahn SM, Zhou P, Zhand YJ, Infante AS. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8: 3447-57.
20. Jares P, Fernandes PL, Campo E, Nadal A, Bosch F, Cardesa A. PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994; 54: 4813-7.
21. Xu J, Gimenez-Conti IB, Cunningham JE, et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998; 83: 204-12.
22. Yokoyama J, Shiga K, Sasano H, Suzuki M, Takasaka T. Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers. Anticancer Res 1996; 16: 641-6.
23. Strauss M, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Nature Med 1995; 1: 1245-6.
24. Sofer-Leui Y, Resnitzky D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 1996; 13: 2431-7.
25. Lam KY, Ng IO, Yuen AP, Kwong DL, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med 2000; 29: 167-72.
26. Mialhe A, Louis J, Montlevier S, et al. Expression of E-cadeherin and alpha-, beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors? Invas Metas 1997; 17: 124-37.
27. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metas Rev 1999; 18: 15-30.
28. Lin SC, Chang KW, Chang CS, et al. Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese. J Oral Pathol Med 2000; 29: 159-66.
29. Kuo MYP, Lin CY, Hahn LJ, Chebg SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 165-9.
30. Saito T, Nakajima T, Morgi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Medical 1999; 28: 226-32.
31. Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 1998; 186: 8-16.
32. Lo ML, Staibano S, Pannone G, et al. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 1999; 19: 3817-26.
33. Chiang CP, Huang JS, Wang JT, Liu BY, Kuo MY. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing-associated oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 1999; 28: 72-6.
34. Kapranos N, Stathopoulos GP, Manolopoulos L, et al. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res 2001; 21: 521-8.
35. Stoll C, Baretton G, Lohrs U. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma. Virchows Arch 1998; 433: 427-33.
36. Lin SC, Chen YJ, Hsu MD, et al. The chromosomal changes of oral squamous cell carcinoma associated with areca quid use. Oral Oncol 2002; 38: 266-73.
37. Callender T, El-Nagar AK, Lee MS, et al. PRMD-1/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994; 30: 113-20.
38. Michalides R, Van Veelen N, Hart A, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 975-8.
39. Chow V, Yuen AP, Lam KY, Tsao GS, Ho WK, Wei WI. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clinic Oncol 2001; 127: 59-63.